Workstream Type: Policy Solutions

  • Abandon Biosimilars as Biologics are Natural Monopolies

  • List Price, Net Price, and the Rebate Caught in the Middle

  • Overview of Original Subscription Model and Features of LA and WA Proposals

    Overview of Original Subscription Model and Features of LA and WA Proposals

  • The “Netflix Model” of Financing Hepatitis C Treatment

    The “Netflix Model” of Financing Hepatitis C Treatment

  • Perspective on National Coverage Analysis of CAR-T Therapies

    Perspective on National Coverage Analysis of CAR-T Therapies

  • The U.S. Government Should Buy Gilead for $156Bn to Save Money on Hep C

  • Part B Payment for Medicare Drugs

    Part B Payment for Medicare Drugs

  • The Just Price of Cancer Drugs

  • Reforming the Payment System for Medical Oncology

  • Comparative Effectiveness Research in Medicare Coverage and Reimbursement